Sector
PharmaceuticalsOpen
₹20.63Prev. Close
₹20.23Turnover(Lac.)
₹0.02Day's High
₹20.63Day's Low
₹20.6352 Week's High
₹28.9752 Week's Low
₹11.92Book Value
₹-2.93Face Value
₹10Mkt Cap (₹ Cr.)
12.07P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.85 | 5.85 | 5.85 | 5.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -7.56 | -7.42 | -3.2 | -3.92 |
Net Worth | -1.71 | -1.57 | 2.65 | 1.93 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 6.32 | 6.59 | 8.17 | 17.18 |
yoy growth (%) | -3.99 | -19.32 | -52.45 | 1.42 |
Raw materials | -3.03 | -4.87 | -4.61 | -12.75 |
As % of sales | 47.91 | 73.96 | 56.43 | 74.23 |
Employee costs | -1.71 | -1.94 | -1.38 | -1.32 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | -1.28 | -3.75 | 0.01 | 0.01 |
Depreciation | -1.02 | -0.42 | -0.72 | -0.95 |
Tax paid | 0 | -0.25 | -0.01 | 0 |
Working capital | -0.42 | -4.52 | 1.6 | -0.11 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.99 | -19.32 | -52.45 | 1.42 |
Op profit growth | -93.07 | -485.05 | -29.03 | 183.11 |
EBIT growth | -66.46 | -1,163.58 | 4.51 | -25.64 |
Net profit growth | -65.9 | -2,08,871.63 | -79.24 | -15.55 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,823.35 | 157.3 | 4,37,806.65 | 237.82 | 0.74 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,140.8 | 81.93 | 1,36,080.52 | 430 | 0.58 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,611.9 | 33.1 | 1,31,478.83 | 1,055.94 | 0.8 | 3,752.25 | 346.4 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,417 | 77.52 | 1,16,513.07 | 469 | 0.81 | 2,394 | 201.77 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,100.5 | 25.69 | 1,12,205.15 | 1,700.8 | 0.27 | 4,035.4 | 156.19 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Mahendra P Shah
ED / MD / Promoter
Kamlesh J Laskari
Non Executive Director
Ranak K Laskari
Independent Non Exe. Director
Devarshi D Patel
Company Sec. & Compli. Officer
Ritu Singh
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Adline Chem Lab Ltd
Summary
Kamron Laboratories Limited (formerly known as Adline Chem Lab Ltd) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The company is engaged primarily in the business of marketing of Pharmaceutical and Nutraceuticals products.In May 1990, the company started production at its site in Rakanpur, Gujarat. Initially, the company was manufacturing tablets, capsules and liquid orals. In 1993, the company started manufacture of injections. At present, the company is marketing its products in many states of India and also exporting to a few countries. But over the period of last three decades, there were major changes in the manufacturing technology and building layout due to which the companys plant became obsolete. After taking shareholders approval, the company had discontinued the production in 2019 and sold its land and building in December 2019. Currently the company is continuing the marketing activities and getting its products manufactured from various manufacturers.
Read More
The Adline Chem Lab Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹20.63 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Adline Chem Lab Ltd is ₹12.07 Cr. as of 05 Sep ‘24
The PE and PB ratios of Adline Chem Lab Ltd is 0 and -7.04 as of 05 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Adline Chem Lab Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Adline Chem Lab Ltd is ₹11.92 and ₹28.97 as of 05 Sep ‘24
Adline Chem Lab Ltd's CAGR for 5 Years at 29.25%, 3 Years at 57.11%, 1 Year at 52.48%, 6 Month at -24.35%, 3 Month at 26.10% and 1 Month at 34.84%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice